Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

Spots can also look very different depending on your skin tone. Some pink, red, or brown spots are more obvious on fair to ...

Art Garfunkel, 83, opened up for the first time about his long standing battle with psoriasis, which recently forced him to ...

Plaque psoriasis on your feet causes similar symptoms as when it develops on other parts of your body. It’s characterized by raised patches of dry and scaly skin. These patches tend to be itchy ...

Post-hoc analyses of the EFFISAYIL 2 trial revealed improvements in Psoriasis Symptom Scale (PSS), Pain Visual Analog Scale ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

2025 — Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and ...

While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...